Home Biotechnology Industry News Consortium lead by Prophylix Pharma AS receives up to €6 M in…

Consortium lead by Prophylix Pharma AS receives up to €6 M in…

The EU grant is for development of a prophylactic treatment to prevent severe bleeding and death in newborns caused by Fetal/Neonatal Alloimmune Trombocytopenia

(PRWeb May 08, 2012)

Read the full story at http://www.prweb.com/releases/2012/5/prweb9483311.htm